AION Labs is building innovative biotechs with top pharma partners in Israel Post date September 12, 2025
Biotech ≠ tech: Why venture capital needs a new playbook for the therapeutics era Post date August 21, 2025
Promise Bio CEO dishes on why Pfizer, AstraZeneca are backing its quest to crack autoimmune trial-and-error Post date July 23, 2025
Study validates DenovAI’s platform for programmable de novo-designed protein therapeutics Post date June 17, 2025
AION Labs Launches 2025 Global Call for Applications: Generative AI for Novel Target Combinations Post date March 5, 2025
AION Labs
AION Labs